Impact of cariprazine on body weight and blood pressure among adults with bipolar I disorder, schizophrenia, or major depressive disorder in a real-world setting
In this real-world analysis, cariprazine was associated with an estimated weight gain of + 0.91 kg/year and had minimal impact on BMI and blood pressure when evaluated up to 12 months.
Authors
- Huy‐Binh Nguyen (ORCID: https://orcid.org/0000-0002-0842-1796)
- François Laliberté (ORCID: https://orcid.org/0000-0003-2601-6214)
- Sean D. MacKnight (ORCID: https://orcid.org/0000-0001-5032-2110)
- Julien Boudreau
- Christoph Ulrich Correll (ORCID: https://orcid.org/0000-0002-7254-5646)
- Guillaume Germain (ORCID: https://orcid.org/0000-0002-4525-7673)
- Nadia Nabulsi (ORCID: https://orcid.org/0000-0003-0632-6311)
- Andrew J. Cutler (ORCID: https://orcid.org/0000-0001-5800-0378)
- Mousam Parikh
- Sally Wade
Institutions
- Northwell Health (US)
- Outcomes Research Consortium (US)
- SUNY Upstate Medical University (US)
- AbbVie (United States) (US)
- Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US)
- German Centre for Cardiovascular Research (DE)
- Zucker Hillside Hospital (US)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Annals of General Psychiatry
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1186/s12991-024-00542-w
- Citations
- 3
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.41